Warning Letter Wednesday Posts
A weekly exploration of FDA warning letters and enforcement trends
Takeaway -
There is a fine line between puffery and marketing claims
Takeaway -
Ensure all data is substantiated
Takeaway -
Measles claims attract scrutiny
Takeaway -
FDA will test “sketchy” products
Takeaway -
Companies are responsible for the products they distribute
Takeaway -
Learn from warning letter citations
Takeaway -
Use caution when using product reviews in marketing
Takeaway -
Learn from National Advertising Division challenges
Takeaway -
Homeopathics + disease claims + risky product category = warning letter
Takeaway -
Complete 483 responses can prevent warning letters
Takeaway -
Small issues add up to big problems
Takeaway -
Disease claims + safety concerns = warning letter